Journal
POLYMERS
Volume 12, Issue 1, Pages -Publisher
MDPI
DOI: 10.3390/polym12010234
Keywords
SAS coprecipitation; controlled drug delivery systems; microparticles; eudragit; supercritical carbon dioxide
Categories
Ask authors/readers for more resources
In this work, the supercritical antisolvent (SAS) process was used to coprecipitate Eudragit L100-55 (EUD) with diclofenac (DICLO) and theophylline (THEOP), with the aim of obtaining composite microparticles with a prolonged drug release for oral delivery. Working at the optimized conditions in terms of pressure and overall concentration in the liquid solution (10.0 MPa and 50 mg/mL), microparticles of EUD/DICLO 20/1 and 10/1 w/w were produced with a mean size of 2.92 mu m and 1.53 mu m, respectively. For the system EUD/THEOP, well-defined spherical microspheres with a mean diameter ranging from 3.75 mu m and 5.93 mu m were produced at 12.0 MPa. The produced composite systems were characterized by various techniques, such as scanning electron microscopy, differential scanning calorimetry, X-ray microanalysis, FT-IR and UV-vis spectroscopy. Dissolution studies showed the potential of EUD to prolong the drug release, significantly, up to a few days.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available